Skip Navigation LinksHome > December 2012 - Volume 40 - Issue 12 > G-protein coupled estrogen receptor 1 mediated estrogenic ne...
Critical Care Medicine:
doi: 10.1097/CCM.0b013e3182657560
Neurologic Critical Care

G-protein coupled estrogen receptor 1 mediated estrogenic neuroprotection against spinal cord injury*

Hu, Rong MD, PhD; Sun, Haodong MD; Zhang, Qian BPharm, MBA; Chen, Jingyu MD; Wu, Nan MD, PhD; Meng, Hui MD, PhD; Cui, Gaoyu MD, PhD; Hu, Shengli MD, PhD; Li, Fei MD, PhD; Lin, Jiangkai MD, PhD; Wan, Qi MD, PhD; Feng, Hua MD, PhD

Collapse Box

Abstract

Objective: What underlies the protection of estrogen against spinal cord injury remains largely unclear. Here, we investigated the expression pattern of a new estrogen receptor, G-protein coupled estrogen receptor 1 in the spinal cord and its role in estrogenic protection against spinal cord injury.

Design and Settings: Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital.

Subjects: Male Sprague–Dawley rats.

Interventions: The animals subjected to spinal cord injury were divided into six groups and given vehicle solution, 17β-estradiol, or G-protein coupled estrogen receptor 1 agonist G-1 at 15 mins and 24 hrs postinjury, or given nuclear estrogen receptor antagonist ICI 182,780 at 1 hr before spinal cord injury followed by 17β-estradiol administration at 15 mins and 24 hrs postinjury, or given G-protein coupled estrogen receptor 1 specific antisense or random control oligonucleotide at 4 days before spinal cord injury followed by 17β-estradiol administration at 15 mins and 24 hrs postinjury.

Measurements: Male Sprague–Dawley rats were subjected to spinal cord injury using a weight-drop injury approach. Immunohistochemical assays were used to observe the distribution and cell-type expression pattern of G-protein coupled estrogen receptor 1. The terminal deoxynucleotidyl transferase dUTP nick-end labeling-staining assay and behavior tests were employed to assess the role of G-protein coupled estrogen receptor 1 in mediating estrogenic protection against spinal cord injury.

Main Results: We show that G-protein coupled estrogen receptor 1 is mainly distributed in the ventral horn and white matter of the spinal cord, which is totally different from nuclear estrogen receptors. We also show that G-protein coupled estrogen receptor 1 is specifically expressed by neurons, oligodendrocytes, and microglial cells, but not astrocytes. Furthermore, estrogen treatment prevents spinal cord injury-induced apoptotic cell death and enhances functional recovery after spinal cord injury, which can be mimicked by the specific G-protein coupled estrogen receptor 1 agonist G-1 and inhibited by specific knockdown of G-protein coupled estrogen receptor 1 expression, but not pure nuclear ER antagonist ICI 182,780. Finally, we show that estrogen or G-1 up-regulates the protein expression level of G-protein coupled estrogen receptor 1 to intensify estrogenic effects during spinal cord injury.

Conclusions: These results reveal that G-protein coupled estrogen receptor 1 may mediate estrogenic neuroprotection against spinal cord injury, and underline the promising potential of estrogen with its new target G-protein coupled estrogen receptor 1 for the treatment of spinal cord injury patients.

© 2012 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.